gastrins has been researched along with Bipolar-Disorder* in 3 studies
1 review(s) available for gastrins and Bipolar-Disorder
Article | Year |
---|---|
[Side-effects and effects of lithium therapy on the endocrinium in man].
Topics: Animals; Bipolar Disorder; Catecholamines; Diabetes Insipidus; Female; Gastrins; Glucagon; Goiter; Humans; Hyperthyroidism; Hypothyroidism; Iodine; Iodine Radioisotopes; Lithium; Middle Aged; Pancreas; Rats; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine | 1973 |
2 other study(ies) available for gastrins and Bipolar-Disorder
Article | Year |
---|---|
Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders.
Vasoactive intestinal polypeptide (VIP), cholecystokinin (CCK) and gastrin in the cerebrospinal fluid (CSF) were studied in patients with endogenous depression, non-endogenous depression, mania, schizophrenia and a control group. All patients were classified according to ICD-9 and the group of depressions was further classified according to the Newcastle Rating Scales for depression (Carney et al. 1965) (N-I). In the group of non-endogenously depressed patients, CSF-VIP levels (median 16 pmol/l) were found to be significantly lower than those of controls (median = 32 pmol/l) and endogenous depressives (36 pmol/l). In the non-endogenous group, it appeared that the low CSF-VIP was due to a group of patients who, during a past or present depressive episode, had been diagnosed as suffering from endogenous depression. Moreover, this group was clinically characterized by 'dysphoric/hysterical features', 'reversed diurnal variation' (i.e. worse in the evening), and 'lack of clearly circumscribed episodes'. In many aspects this group seems similar to the atypical depressives described as monoamine oxidase inhibitor responders. Concerning CSF-CCK and CSF-gastrin, no significant differences between the examined groups were demonstrated. Topics: Adult; Aged; Bipolar Disorder; Cholecystokinin; Depressive Disorder; Female; Gastrins; Humans; Male; Middle Aged; Psychological Tests; Psychotic Disorders; Schizophrenia; Vasoactive Intestinal Peptide | 1984 |
Peptic ulcer complaints in lithium-treated and non-lithium-treated manic-depressive patients.
A possible protective effect of lithium against the occurrence of peptic ulcer complaints in manic-depressive patients, treated with lithium, was investigated. 167 manic-depressive patients, 91 in lithium treatment, 76 not in lithium treatment, were questioned about clinical symptoms of peptic ulcer. Thirteen of the lithium-treated and 23 of the non-lithium-treated patients reported symptoms of peptic ulcer. The difference was statistically significant. The hypothesis that lithium treatment reduces the frequency of symptoms of peptic ulcer in manic-depressive patients was thus confirmed. Topics: Bipolar Disorder; Gastrins; Humans; Lithium; Peptic Ulcer | 1983 |